The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Hematologic malignancies often relapse with refractory disease, reducing patient quality of life.
• Conventional chemotherapies combined with DNA repair inhibitors face challenges due to hematologic toxicity.
• Dbait molecules target DNA damage signaling and double-strand DNA break pathways, showing promise in solid tumors.

Purpose of the Study:

• To evaluate the efficacy and safety of AsiDNA, a cholesterol-conjugated Dbait, in treating hematologic malignancies.
• To investigate AsiDNA's mechanism of action, including cellular uptake and target activation.
• To assess AsiDNA's synergistic potential and toxicity profile when combined with conventional cancer therapies.

Main Methods:

• AsiDNA uptake via LDL receptors and DNA-PKcs activation were analyzed in 10 leukemia/lymphoma cell lines and primary human blood cells.
• Cell death induction (necrotic and mitotic) by AsiDNA was assessed in cancer cell lines and normal hematopoietic cells.
• Synergistic effects and toxicity of AsiDNA combined with etoposide, cyclophosphamides, vincristine, and radiotherapy were evaluated using isobolograms and combination index.

Main Results:

• AsiDNA activated DNA-PKcs in all tested cancer cell lines and primary hematopoietic cells.
• AsiDNA induced significant necrotic and mitotic cell death in cancer cells, with no adverse effects on normal blood or bone marrow cells.
• AsiDNA demonstrated synergistic effects with etoposide, cyclophosphamides, and radiotherapy, without augmenting toxicity to normal hematologic cells.

Conclusions:

• AsiDNA is a potent drug candidate for hematologic malignancies, demonstrating tumor-specific toxicity.
• AsiDNA's ability to synergize with conventional treatments without increasing toxicity offers a significant therapeutic advantage.
• AsiDNA presents a novel strategy to enhance cancer treatment efficacy while preserving normal hematologic function and avoiding immune dysregulation.